Liu, X. (2018). A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationLiu, X. A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationLiu, X. A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.